Chile reviews AUGE coverage upgrade:
This article was originally published in Clinica
Executive Summary
In the month to August 1, Chile's AUGE (universal healthcare access with explicit guarantees) programme provided care to almost 27,000 patients of cases involving the 16 conditions that gained coverage on July 1, taking the total to 56 (see Clinica No 1264, p 3). The vast majority of cases, just over 20,000, were for emergency dental surgery; of the remainder, almost 1,100 were for hearing aids; others included cataract and gastric surgery. All but 283 patients (those covered by private contribution schemes, ISAPREs) were covered by the national health insurance fund, Fonasa. AUGE is cofinanced by the state and the private health insurance sector.
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.